Skip to main content

Table 2 Comparison of background parenchymal uptake, assessed quantitatively, on pre-tamoxifen and post-tamoxifen MBI

From: Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study

  Quantitative BPU on pre-tamoxifen MBI, mean (sd, range) Quantitative BPU on post-tamoxifen MBI, mean (sd, range) % change, mean (sd, range) p
Overall (n = 21) 1.43 (0.32, 0.81–2.17) 1.34 (0.38, 0.74–2.10) − 6.1% (17%, − 31 to + 45%) 0.11
Women taking 5 mg tamoxifen (n = 10) 1.53 (0.30, 1.12–2.17) 1.51 (0.34, 1.13–2.10) 0.0% (21%, − 24.0 to + 45%) 0.99
Women taking 10 mg tamoxifen (n = 11) 1.34 (0.32, 0.81–2.13) 1.19 (0.35, 0.74–1.75) − 12% (11%, − 31 to + 7%) 0.005
  1. BPU background parenchymal uptake, MBI molecular breast imaging